ID: ALA3580760

Max Phase: Preclinical

Molecular Formula: C30H29Cl3N10O4

Molecular Weight: 663.53

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1CCN(C(=O)C[C@H](NC(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)c2nc(-c3ccc4[nH]c(=O)cc(O)c4c3)c(Cl)[nH]2)CC1.Cl

Standard InChI:  InChI=1S/C30H28Cl2N10O4.ClH/c1-40-8-10-41(11-9-40)27(46)14-22(35-25(44)7-3-17-12-19(31)4-6-23(17)42-16-33-38-39-42)30-36-28(29(32)37-30)18-2-5-21-20(13-18)24(43)15-26(45)34-21;/h2-7,12-13,15-16,22H,8-11,14H2,1H3,(H,35,44)(H,36,37)(H2,34,43,45);1H/b7-3+;/t22-;/m0./s1

Standard InChI Key:  PKVVLVYNVQAUEP-BWHJXNDYSA-N

Associated Targets(non-human)

Cynomolgus monkey 4946 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Canis familiaris 36305 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Oryctolagus cuniculus 11301 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 663.53Molecular Weight (Monoisotopic): 662.1672AlogP: 2.94#Rotatable Bonds: 8
Polar Surface Area: 178.02Molecular Species: NEUTRALHBA: 10HBD: 4
#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 6.61CX Basic pKa: 7.25CX LogP: 0.78CX LogD: 0.66
Aromatic Rings: 5Heavy Atoms: 46QED Weighted: 0.18Np Likeness Score: -1.35

References

1. Hu Z, Wong PC, Gilligan PJ, Han W, Pabbisetty KB, Bozarth JM, Crain EJ, Harper T, Luettgen JM, Myers JE, Ramamurthy V, Rossi KA, Sheriff S, Watson CA, Wei A, Zheng JJ, Seiffert DA, Wexler RR, Quan ML..  (2015)  Discovery of a Potent Parenterally Administered Factor XIa Inhibitor with Hydroxyquinolin-2(1H)-one as the P2' Moiety.,  (5): [PMID:26005539] [10.1021/acsmedchemlett.5b00066]

Source